What level of serum calcitonin indicates medullary thyroid carcinoma in patients with chronic kidney disease?

Nature Clinical Practice Nephrology

Volumn 3, Issue 5, 2007, Pages 246-247

  Meyrier, Alain ^a  

^a HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

C cell hyperplasia; Calcitonin; Chronic kidney disease; Medullary thyroid carcinoma

Indexed keywords

CALCITONIN; PENTAGASTRIN; TUMOR MARKER;

AUSTRIA; BOLUS INJECTION; CALCITONIN BLOOD LEVEL; CANCER CELL; CANCER DIAGNOSIS; CANCER SURGERY; CELL HYPERPLASIA; CELL TYPE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; DIAGNOSTIC ACCURACY; DIALYSIS; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; ECHOGRAPHY; HISTOPATHOLOGY; HUMAN; KIDNEY ALLOGRAFT; NOTE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; STATISTICAL SIGNIFICANCE; THYROID MEDULLARY CARCINOMA; THYROIDECTOMY; TUMOR VOLUME;

EID: 34247568332     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0464     Document Type: Note

References (5)

1. Leboulleux S et al. (2004) Medullary thyroid carcinoma. Clin Endocrinol (Oxf) 61: 299-310
2. Messa P et al. (1995) The calcitonin-calcium relation curve and calcitonin secretory parameters in renal patients with variable degrees of renal function. Nephrol Dial Transplant 10: 2259-2265
3. Karanikas G et al. (2004) Frequency and relevance of elevated calcitonin levels in patients with neoplastic and nonneoplastic thyroid disease and in healthy subjects. J Clin Endocrinol Metab 89: 515-519
4. Costante G et al. (2007) Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 92: 450-455
5. Papi G et al. (2006) Value of routine measurement of serum calcitonin concentrations in patients with nodular thyroid disease: a multicenter study. J Endocrinol Invest 29: 427-437